Nuclaze ™ 200
Nuclaze™ 200 is an oral antifungal formulation designed to assist healthcare professionals in the management of moderate to extensive fungal infections requiring systemic intervention. The formulation supports dermatological care where sustained antifungal coverage is clinically indicated.
It helps maintain therapeutic management of fungal infections affecting skin, nails, and related structures.
Dosage Form
Capsules
Therapeutic Category
Antifungal
Strength
200 mg
Pack Size
10 × 1 × 10 Alu-Alu
Route of Administration
Oral
Formulated For
Physician-directed systemic antifungal therapy
Brand
Indigammy
Nuclaze™ 200 contains Itraconazole, a broad-spectrum triazole antifungal that interferes with ergosterol synthesis necessary for fungal cell membrane stability.
By assisting in reducing fungal proliferation, the formulation supports management of persistent dermatophytic and yeast infections. The higher strength provides dosing flexibility based on infection severity and physician assessment.